The trigeminal retrograde transfer pathway in the treatment of neurodegeneration

Stephanos Kyrkanides; Meixiang Yang; Ross H. Tallents; Jen nie H. Miller; Sabine M. Brouxhon; John A. Olschowka

doi:10.1016/j.jneuroim.2009.02.006

The trigeminal retrograde transfer pathway in the treatment of neurodegeneration

Stephanos Kyrkanides, Meixiang Yang, Ross H. Tallents, Jen nie H. Miller, Sabine M. Brouxhon, John A. Olschowka

Oral Health Science

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

The trigeminal sensory system was evaluated for the retrograde transfer of gene therapy vectors into the CNS. The feline immunodeficiency viral vector, FIV(HEXB), encoding for the human HEXB gene, was injected intra-articularly in the temporomandibular joint of 12 week-old HexB^-/- mice displaying clinical and histopathological signs of Sandhoff disease. This treatment regiment reduced GM₂ storage and ameliorated neuroinflammation in the brain of HexB^-/- mice, as well as attenuated behavioral deficits. In conclusion, retrograde transfer along trigeminal sensory nerves may prove to be a valuable route of gene therapy administration for the treatment of lysosomal storage disorders and other neurodegenerative diseases.

Original language	English
Pages (from-to)	139-142
Number of pages	4
Journal	Journal of Neuroimmunology
Volume	209
Issue number	1-2
DOIs	https://doi.org/10.1016/j.jneuroim.2009.02.006
State	Published - Apr 30 2009

Bibliographical note

Funding Information:
This work was funded in part by grant NS048339 from the National Institutes of Health.

Keywords

GM gangliosidosis
Mouse, Gene therapy
Sandhoff disease
β-hexosaminidase

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Neurology
Clinical Neurology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jneuroim.2009.02.006

Cite this

@article{17280340c6a144e0a5fa204724185911,

title = "The trigeminal retrograde transfer pathway in the treatment of neurodegeneration",

abstract = "The trigeminal sensory system was evaluated for the retrograde transfer of gene therapy vectors into the CNS. The feline immunodeficiency viral vector, FIV(HEXB), encoding for the human HEXB gene, was injected intra-articularly in the temporomandibular joint of 12 week-old HexB-/- mice displaying clinical and histopathological signs of Sandhoff disease. This treatment regiment reduced GM2 storage and ameliorated neuroinflammation in the brain of HexB-/- mice, as well as attenuated behavioral deficits. In conclusion, retrograde transfer along trigeminal sensory nerves may prove to be a valuable route of gene therapy administration for the treatment of lysosomal storage disorders and other neurodegenerative diseases.",

keywords = "GM gangliosidosis, Mouse, Gene therapy, Sandhoff disease, β-hexosaminidase",

author = "Stephanos Kyrkanides and Meixiang Yang and Tallents, {Ross H.} and Miller, {Jen nie H.} and Brouxhon, {Sabine M.} and Olschowka, {John A.}",

note = "Funding Information: This work was funded in part by grant NS048339 from the National Institutes of Health.",

year = "2009",

month = apr,

day = "30",

doi = "10.1016/j.jneuroim.2009.02.006",

language = "English",

volume = "209",

pages = "139--142",

number = "1-2",

}

TY - JOUR

T1 - The trigeminal retrograde transfer pathway in the treatment of neurodegeneration

AU - Kyrkanides, Stephanos

AU - Yang, Meixiang

AU - Tallents, Ross H.

AU - Miller, Jen nie H.

AU - Brouxhon, Sabine M.

AU - Olschowka, John A.

N1 - Funding Information: This work was funded in part by grant NS048339 from the National Institutes of Health.

PY - 2009/4/30

Y1 - 2009/4/30

N2 - The trigeminal sensory system was evaluated for the retrograde transfer of gene therapy vectors into the CNS. The feline immunodeficiency viral vector, FIV(HEXB), encoding for the human HEXB gene, was injected intra-articularly in the temporomandibular joint of 12 week-old HexB-/- mice displaying clinical and histopathological signs of Sandhoff disease. This treatment regiment reduced GM2 storage and ameliorated neuroinflammation in the brain of HexB-/- mice, as well as attenuated behavioral deficits. In conclusion, retrograde transfer along trigeminal sensory nerves may prove to be a valuable route of gene therapy administration for the treatment of lysosomal storage disorders and other neurodegenerative diseases.

AB - The trigeminal sensory system was evaluated for the retrograde transfer of gene therapy vectors into the CNS. The feline immunodeficiency viral vector, FIV(HEXB), encoding for the human HEXB gene, was injected intra-articularly in the temporomandibular joint of 12 week-old HexB-/- mice displaying clinical and histopathological signs of Sandhoff disease. This treatment regiment reduced GM2 storage and ameliorated neuroinflammation in the brain of HexB-/- mice, as well as attenuated behavioral deficits. In conclusion, retrograde transfer along trigeminal sensory nerves may prove to be a valuable route of gene therapy administration for the treatment of lysosomal storage disorders and other neurodegenerative diseases.

KW - GM gangliosidosis

KW - Mouse, Gene therapy

KW - Sandhoff disease

KW - β-hexosaminidase

UR - http://www.scopus.com/inward/record.url?scp=64549099776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64549099776&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2009.02.006

DO - 10.1016/j.jneuroim.2009.02.006

M3 - Article

C2 - 19278737

AN - SCOPUS:64549099776

SN - 0165-5728

VL - 209

SP - 139

EP - 142

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

IS - 1-2

ER -

The trigeminal retrograde transfer pathway in the treatment of neurodegeneration

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this